Alternative to Meds Center has expanded its educational resources on Caplyta side effects. Whenever a newer medication ...

Patients with chronic kidney disease and type 2 diabetes receiving pharmacist-led outreach were nearly twice as likely to start an SGLT2 inhibitor as those receiving usual care.

ITA testing chief Oliver Banuls explains how riders' power data could become the next intelligence tool in cycling's fight ...

Objectives Treatment of rheumatoid arthritis (RA) relies on immunomodulatory drugs that can compromise immunity, inducing secondary immunodeficiency (SID). However, features of SID, such as ...

Discover the best Series 7 exam prep courses. Learn how the best prep courses compare in terms of costs, course structure, ...

Cancer cells are quick to develop resistance to anti-tumor drugs. New research by scientists from the University of ...

After one year, people taking a GLP-1 drug had better outcomes than those taking an SGLT-2 drug. Specifically, they were 36% less likely to die from any cause, 12% less likely to be hospitalized, 22% ...

What do Botox, rat poison, weight-loss drugs and a fictional murder investigation have in common? At the University of Nevada ...

Replimune Group, Inc. nears a pivotal FDA AdCom for RP1 ahead of an Aug 2, 2026 decision. Click for this REPLY stock update ...

RNA interference is a natural mechanism for living cells to control whether specific genes are being used. Crowned with the ...

ABO-101 is an investigational gene editing therapy designed to address the underlying disease biology of PH1 by reducing hepatic oxalate ...

Favourable safety profile in marked contrast to traditional inotropic therapeuticsAC01 showed rapid and sustained numerical ...